Please login to the form below
top 10
This page shows the latest top 10 news and features for those working in and with pharma, biotech and healthcare.
ICR scientists create AI test to predict cancer drug combinations
Of the 128, the AI test correctly identified the top five ranked combinations 57% of the time, while it correctly identified the top 10 ranked combinations 83% of the time.
Latest news
-
Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA
Although the mortality rate for COVID-19 in children is substantially lower than that in adults, COVID-19 was among the top 10 leading causes of death for children 5 to ... Children aged 5-11 years received a two-dose regimen of 10 µg administered 21
-
Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops
Total product sales fell 10% to $5.1bn in the second quarter of the year, compared to $5.6bn in the same quarter last year and below analyst expectations.
-
PMLiVE launches its inaugural T40
Congratulations to the top 10 overall:. Havas Lynx Group. McCann Health. ... Please see separate links for:. Top 10 smaller agencies.
-
Pharma ranks bottom in Gallup poll of industry reputation
The government mustered -27 and healthcare -10, while at the top end of the scale came the restaurant industry (58), the computer sector (50) and grocery (43).
-
Gilead strikes $5.1bn deal to bolster ties with Galapagos
The 10-year R&D alliance could swell Gilead’s pipeline by up to six compounds in the clinic and 20 preclinical programmes, at a time when the biotech is still ... Meanwhile, for Galapagos, the partnership massively increases its financial muscle as it
More from news
Approximately 0 fully matching, plus 96 partially matching documents found.
Latest Intelligence
-
Is there such a thing as the new normal? Or is it simply the ‘here and now’?
Most of the world’s Top 10 companies are tech businesses but pharma has only just opened the box of ‘digital transformation’ and now has to plug it in to become
-
The European Medicines Agency: PRIME’d for access?
n = 36. PRIME isn’t just for big companies: up to March 2018 just nine of the companies - with 10 PRIME treatments - are in the top 50 companies of 2017 by ... sales, and 6 are in the top 10 companies with Pfizer (with Spark Therapeutics), Novartis (by
-
The good, the bad and the ugly
The second half of the top 10 European companies is taken up by five companies that do not feature among the top 10 global pharma. ... The latter enjoyed a sales uplift of 16.3%, making it one of seven companies in the top 10 outfits to deliver strong
-
The tipping point
If we project forward to 2020, seven of the top 10 global medicines by spend will be biologics. ... If we take the top 20 biologics by spend, in two years, 15 of these will have biosimilars.
-
Brexit: the facts (and the alternative facts)
Two of the top 10 biopharma companies (GSK and AstraZeneca) have UK HQs and nearly 10% of the top 100 drugs available today originated from UK-based research. ... Moreover, it has been estimated that a further 10.0bn of funding is at risk by 2020.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
Taiho Oncology names Timothy Whitten as president
a top 10 oncology company globally.
-
Virgo Consumer Health & Wellbeing hires Kirsty McKinnon
She joins as associate director from MSL London, with over 10 years' experience across top consumer health and wellbeing brands including P&G's Prestige, Femcare and Personal Care portfolios as
-
Lilly names head of corporate business development
innovation. “It has been recognised by partners that range from start-ups to other top 10 pharmaceutical companies, and it is a critical reason why we are attractive as a partner.
-
Peix appoints online marketing manager
Peix Pharma is one of Germany's top 10 pharmaceutical communications agencies.
-
Sanofi appoints ‘chief patient officer’
Smaller firms, such as UCB, have already embraced this model with the appointment of a chief patient officer, but Sanofi is the first top 10 company to create such a role.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform for internal MSL/Sales training programs and events. ... In this top-10 article, we share 10 innovative ways that life science teams can leverage the Impetus InSite Platform for internal MSL/Sales
-
Top 10 Benefits of Virtual Advisory Boards
In this article, based on a 2019 Impetus Digital white paper, I share the top 10 benefits (a bonus) of virtual advisory boards and why they should be part of every
-
Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?
With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and why and how should Pharma companies leverage them? A
-
Top 10 Creative Ways to Engage Your Advisors
Irrespective of whether you have worked with us in the past or are new to the world of virtual customer collaboration, I wanted to share our top 10 creative ways to
-
Top-10 Tips for a Sustainable Home Office
In our recent article, we share our top-10 tips for “greening” your WFH space!
More from PMHub
Approximately 10 fully matching, plus 46 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Engaging KOLs and Gaining Insights in Pharma's New Normal
- That ‘don’t’ impress me much
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
PMHub
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...
Latest intelligence
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
- How the Royal Society’s EiR programme can help to drive UK innovation
- ...
